Sheets Smith Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,234
Closed -$572K 315
2019
Q4
$572K Sell
6,234
-280
-4% -$23.5K 0.11% 185
2019
Q3
$500K Buy
6,514
+141
+2% +$12.3K 0.1% 195
2019
Q2
$548K Buy
+6,373
New +$434K 0.11% 192

Other funds holding RGEN

Sheets Smith Wealth Management's RGEN Position: Q1 2020 in Review

Sheets Smith Wealth Management sold out of Repligen (RGEN) in Q1 2020, closing a stake of 6,234 shares — an estimated $572K sold.

Sheets Smith Wealth Management first reported a position in RGEN in Q2 2019 and held it in 3 quarters. The position peaked at $572K in Q4 2019. 309 funds tracked by Wall St. Rank hold RGEN as of Q1 2020.

  • Sheets Smith Wealth Management reported no remaining Repligen position as of Q1 2020 after selling out during the quarter.
  • Sheets Smith Wealth Management sold 6,234 Repligen shares in Q1 2020, an estimated $572K.
  • Sheets Smith Wealth Management first reported a position in Repligen in Q2 2019 and held it in 3 quarters.
  • Sheets Smith Wealth Management's Repligen position peaked at $572K in Q4 2019.
  • 309 funds tracked by Wall St. Rank held Repligen as of Q1 2020.

Based on Sheets Smith Wealth Management's 13F filing for Q1 2020, filed 28 Apr 2020.